ARTICLE | Clinical News
Tracleer bosentan regulatory update
July 13, 2009 7:00 AM UTC
The European Commission approved a 32 mg pediatric formulation of Tracleer bosentan to treat pulmonary arterial hypertension (PAH) in children. Actelion plans to launch the new formulation in Germany ...